Craft

Delta-Fly Pharma

Stock Price

¥533

2024-10-29

Market Capitalization

¥4.5 B

2024-10-29

Delta-Fly Pharma Summary

Company Summary

Overview
Delta-Fly Pharma 株式会社(デルタフライファーマ is a manufacturer and seller of anti-cancer agents and other products. It offers polymer technology, treatment for lung cancer, solid tumor, and other products. The company caters to the healthcare and technology sectors.
Type
Public
Status
Active
Founded
2010
Website
http://delta-flypharma.co.jp
Cybersecurity rating
Sectors

Table of Contents

Delta-Fly Pharma Financials

Summary Financials

Gross profit (H1, 2026)
¥718.0K
Net income (H1, 2026)
(¥841.8M)
Cash (H1, 2026)
¥435.4M
EBIT (H1, 2026)
(¥831.2M)

Footer menu